Skip to main content
HairCited

Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review.

Robert J Dabek, Daniel S Roh, Derman Ozdemir, William G Austen, Branko Bojovic
Review Cureus 2019 18 件の引用
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D31453018'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究タイプ
systematic_review
介入
Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review. fractional laser therapy (6 laser types) or microneedling (2 studies) — with or without topical agen
比較対照
Placebo
効果の方向
Positive
バイアスリスク
High

Abstract

Alopecia areata (AA) affects approximately 2.1% of the population, with women being affected more often than men. Current therapies consisting of topical corticosteroids or intralesional injections are often the first choices for treatment, but are limited by unsatisfactory outcomes or risks to patients. Recently, fractional lasers and microneedling, with or without the addition of topical agents, have been examined as treatment options. A literature review was performed to evaluate the efficacy of fractional lasers in the treatment of AA. A total of six fractional lasers and two microneedling studies consisting of small prospective and retrospective studies, and case reports were reviewed. The number of trials and participants are limited, but evidence suggests that fractional lasers and microneedling may be effective therapeutic approaches when coupled with topical agents. Larger studies are required to better understand the effects of these treatment modalities for AA.

Full Text

PDF
Loading PDF...

Tables

Table 1

Author, yearResurfacing techniqueAdditional treatment(s)Study DesignLaser/needling settings  Number of sessionsIntervalNumber of SubjectsAlopecia typeAdverse effectsresults
Yalici-Armagan et al., 2016 [21]CO2 laser (10600 nm)     Nd:YAG* laser (1064 nm)NoneProspective, split lesion study10-45 mJ/cm2, 75-100 spots/cm2     10 J/cm2, 30 millisecond pulse3-6    2-4 weeks   2-8 weeks32 (19 male, 13 female)Alopecia areataPainNo improvement
Issa et al., 2016 [22]CO2 laser (10600 nm)  Topical corticosteroidProspective study60 mJ/spot, 100 spots/cm2, 2 passes1-63 weeks5 (1 male, 4 female)Alopecia areataMild burning painImprovement in all patients
Eckert et al., 2016 [23]Erbium glass laser (1550 nm)NoneRetrospective seriesVariable2-33-6 weeks5 (2 male, 3 female)Alopecia areataPainImprovement in all treated lesions
Cho et al., 2013 [24]CO2 laser (10600 nm)   Erbium glass laser (1550 nm)VariableRetrospective series30-50 mJ/spot, 150 spots/cm2   6-8 mJ/spot, 300 spots/cm2 2-33-6 weeks3 (1 male, 2 female)OphiasisPain, crusting, scaling, erythema, and edema2 of 3 patients demonstrated improvement
Tsai, 2011 [25]Erbium glass laser (1550 nm)Intralesional corticosteroid injectionSplit scalp case reportNot reported121 week1 maleAlopecia areataNoneImprovement vs steroid alone
Yoo et al., 2010 [26]Erbium glass laser (1550 nm)NoneCase report10-15 mJ/spot, 300 spots/cm2, 2 passes241 week1 maleAlopecia areataNoneComplete regrowth in treated lesions
Mysore et al., 2014 [27]Microneedle dermarollerTopical corticosteroidsCase series 33 weeks2 malesAlopecia areataNoneImprovement  
Yoo et al., 2010 [28]1 mm microneedle rollerTopical methyl 5-aminolevulinate acid and photodynamic therapy with red lightSplit lesion case series 34 weeks8 (2 male, 6 female)Alopecia areataMild pain, and erythemaNo improvement

References

  1. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009 J Invest Dermatol, 2014
  2. Guidelines for the management of alopecia areata Br J Dermatol, 2003
  3. Review of quality of life studies in women with alopecia Int J Womens Dermatol, 2018
  4. Alopecia areata: a review of disease pathogenesis Br J Dermatol, 2018
  5. Histopathology of alopecia: a clinicopathological approach to diagnosis Histopathology, 2010
  6. The histopathology of noncicatricial alopecia Semin Cutan Med Surg, 2006
  7. Histopathologic features of alopecia areata: a new look Arch Dermatol, 2003
  8. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis J Am Acad Dermatol, 2003
  9. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial J Eur Acad Dermatol Venereol, 2006
  10. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream Arch Dermatol, 2000
  11. British Association of Dermatologists’ guidelines for the management of alopecia Br J Dermatol, 2012
  12. Topical minoxidil in the treatment of alopecia areata Br Med J, 1983
  13. Extensive alopecia areata. results of treatment with 3% topical minoxidil Cleve Clin J Med, 1989
  14. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata J Am Acad Dermatol, 1987
  15. A trial of 1% minoxidil used topically for severe alopecia areata Acta Derm Venereol, 1986
  16. Treatment of alopecia areata with dinitrochlorobenzene Arch Dermatol, 1978
  17. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis Br J Dermatol, 1995
  18. Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata J Am Acad Dermatol, 1999
  19. Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay J Am Acad Dermatol, 1987
  20. 1-chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium Mutat Res, 1980
  21. The effect of neodymium: yttrium aluminum garnet and fractional carbon dioxide lasers on alopecia areata: a prospective controlled clinical trial Dermatol Surg, 2016
  22. Transepidermal drug delivery: a new treatment option for areata alopecia? J Cosmet Laser Ther, 2015
  23. Alopecia areata: good response to treatment with fractional laser in 5 cases J Cosmo Trichol, 2016
  24. Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients J Cosmet Laser Ther, 2013
  25. Alopecia areata treated with fractional photothermolysis laser: a case report J Am Acad Dermatol, 2016
  26. Treatment of alopecia areata with fractional photothermolysis laser Int J Dermatol, 2010
  27. Alopecia areata-successful outcome with microneedling and triamcinolone acetonide J Cutan Aesthet Surg, 2014
  28. Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration Dermatol Surg, 2010
  29. Laser modulation of hypertrophic scars: technique and practice Clin Plast Surg, 2017
  30. Overview of lasers used in dermatology Handbook of Lasers in Dermatology, 2014
  31. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury Lasers Surg Med, 2004
  32. Hair induction after laser-assisted hair removal and its treatment J Am Acad Dermatol, 2006
  33. Lasers may induce terminal hair growth Dermatol Surg, 2006
  34. Update of ablative fractionated lasers to enhance cutaneous topical drug delivery Adv Ther, 2017
  35. Needling-assisted drug delivery: enhanced response to ingenol mebutate after microneedling Dermatol Surg, 2017

Used In Evidence Reviews

Similar Papers